Eli Lilly is dropping CVS Health's drug benefit plan for its employees after CVS stopped covering its weight-loss drug in ...

Even by dramatically lowering the prices of some of its medications, the drug giant is still outpacing its rivals and nearing ...

David Ricks' remarks followed a recent White House event where Trump announced his administration had reached a deal to lower ...

Eli Lilly has penned a research pact worth $1.2 billion in biobucks with SanegeneBio to help pinpoint cardiometabolic RNAi ...

Lilly's shares have taken off in the wake of several significant deals and after it received fast-track regulatory review for ...

Shares of Eli Lilly were surging on Tuesday as investors took a positive long-term view of the [company's recent agreement]( ...

Shares of Eli Lilly & Co. are being fueled by enthusiasm over the company's recent deal with the Trump administration. As Jaimy Lee reports, this enthusiasm is based in part on the addition of ...

Trump announces deal with Eli Lilly, Novo Nordisk to lower cost of GLP-1 weight loss drugs Wegovy, Zepbound. Here's what to ...

Eli Lilly shares are rising Monday after Leerink Partners upgraded the stock to Outperform and raised its price target to ...

For long-term investors, there are plenty of reasons to buy and hold Eli Lilly for not only years but decades.

Early results of Eli Lilly’s next generation of weight loss drugs appear to show promise, possibly leading to even faster ...

In the preceding three months, 12 analysts have released ratings for Eli Lilly (NYSE: LLY ), presenting a wide array of perspectives from bullish to bearish. The following table summarizes their ...